𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancer

✍ Scribed by Robert F. Hoedemaeker; John B. W. Rietbergen; Ries Kranse; Theodorus H. van der Kwast; Fritz H. Schröder

Publisher
Springer-Verlag
Year
1997
Tongue
English
Weight
693 KB
Volume
15
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changing role of 3 screening modalities
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)
✍ P.M.M. Beemsterboer; R. Kranse; H.J. de Koning; J.D.F. Habbema; F.H. Schröder 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB 👁 2 views

A randomized screening trial was started in Europe to show the effect of early detection and treatment of prostate cancer on mortality (European Study on Screening of Prostate Cancer). In one centre (Rotterdam), the screening protocol initially consisted of 3 screening tests for all men: prostate-sp

PSA doubling time predicts the outcome a
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section
✍ Khatami Ali; Aus Gunnar; Damber Jan-Erik; Lilja Hans; Lodding Pär; Hugosson Jona 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni

Predictors for biopsy outcome in the Eur
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)
✍ Kranse, Ries; Beemsterboer, Petra; Rietbergen, John; Habbema, Dik; Hugosson, Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

In the European Randomized Study of Screening for Prostate Cancer (ER-SPC, Rotterdam region), men aged 55-74 years are screened for prostate cancer by prostatespecific antigen (PSA) sampling, digital rectal examination (DRE), and transrectal ultrasound investigation (TRUS). All men with a PSA Ն4 ng/

Screen-detected prostate cancer and the
Screen-detected prostate cancer and the insulin-like growth factor axis: Results of a population-based case-control study
✍ Steven E. Oliver; David Gunnell; Jenny Donovan; Tim J. Peters; Raj Persad; David 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 86 KB 👁 1 views

## Abstract Higher circulating levels of IGF‐I have been associated with increased risk of prostate and some other cancers. Most research on prostate cancer has been based on men with symptoms or identified following treatment of benign disease. However, increasing numbers of cancer cases are now d